Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

PSYCHOPHARMACOLOGY

卷 167, 期 2, 页码 219-220

SPRINGER

-

Neurosciences Pharmacology & Pharmacy Psychiatry

1. NIAAA NIH HHS [KO2 AA 0261-01] Funding Source: Medline